Mind Medicine (MindMed) (MNMD) Insider Trading & Ownership $7.76 -0.63 (-7.51%) (As of 11/15/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipShort InterestTrends Mind Medicine (MindMed) (NASDAQ:MNMD) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage2.26%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$24,085.00Number OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$649,018.79 Get MNMD Insider Trade Alerts Want to know when executives and insiders are buying or selling Mind Medicine (MindMed) stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address MNMD Insider Buying and Selling by Quarter Ad Weiss RatingsThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin conference in Nashville … Where he told an adoring crowd that the U.S. would become … “The crypto capital of the planet and the Bitcoin superpower of the world.”Click here to find out more about what could be Trump and JD Vance’s favorite coin. Mind Medicine (MindMed) Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/25/2024Carrie LiaoCAOSell2,352$5.98$14,064.96 9/25/2024Dan KarlinInsiderSell6,871$5.98$41,088.58 9/25/2024Robert BarrowCEOSell19,771$5.98$118,230.58 8/23/2024David W GryskaDirectorBuy3,500$5.98$20,930.00 8/19/2024Robert BarrowCEOBuy500$6.31$3,155.00 6/25/2024Dan KarlinInsiderSell6,925$7.22$49,998.50 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 6/25/2024Robert BarrowCEOSell15,659$7.22$113,057.98 3/25/2024Dan KarlinInsiderSell6,578$9.50$62,491.00 3/25/2024Robert BarrowCEOSell16,519$9.50$156,930.50 12/26/2023Dan KarlinInsiderSell6,774$3.63$24,589.62 12/26/2023Robert BarrowCEOSell13,237$3.63$48,050.31 12/26/2023Schond L GreenwayCFOSell5,652$3.63$20,516.76 (Data available from 1/1/2013 forward) MNMD Insider Trading Activity - Frequently Asked Questions Who is on Mind Medicine (MindMed)'s Insider Roster? The list of insiders at Mind Medicine (MindMed) includes Carrie Liao, Dan Karlin, David W Gryska, Robert Barrow, and Schond L Greenway. Learn more on insiders at MNMD. What percentage of Mind Medicine (MindMed) stock is owned by insiders? 2.26% of Mind Medicine (MindMed) stock is owned by insiders. Learn more on MNMD's insider holdings. Which Mind Medicine (MindMed) insiders have been buying company stock? The following insiders have purchased MNMD shares in the last 24 months: David W Gryska ($20,930.00), and Robert Barrow ($3,155.00). How much insider buying is happening at Mind Medicine (MindMed)? Insiders have purchased a total of 4,000 MNMD shares in the last 24 months for a total of $24,085.00 bought. Which Mind Medicine (MindMed) insiders have been selling company stock? The following insiders have sold MNMD shares in the last 24 months: Carrie Liao ($14,064.96), Dan Karlin ($240,383.42), Robert Barrow ($573,626.51), and Schond L Greenway ($154,376.72). How much insider selling is happening at Mind Medicine (MindMed)? Insiders have sold a total of 197,359 Mind Medicine (MindMed) shares in the last 24 months for a total of $982,451.61 sold. Mind Medicine (MindMed) Key ExecutivesMr. Robert Barrow (Age 35)CEO & Director Compensation: $931.13k3 recent tradesDr. Daniel Rollings Karlin M.A. (Age 44)M.D., Chief Medical Officer Compensation: $658.52kDr. Miriam Halperin Wernli B.A. (Age 71)M.A., M.B.A., MBA, Ph.D., Executive President Compensation: $552.46kDr. Scott M. Freeman M.D. (Age 67)Co-Founder & Clinical Advisor Compensation: $319.73kMr. Leonard LatchmanCo-founderMs. Carrie F. Liao CPA (Age 58)CGMA, VP & Chief Accounting Officer 1 recent tradesMr. Mark R. Sullivan J.D. (Age 53)Chief Legal Officer & Corporate Secretary Dr. Francois P. Lilienthal M.B.A.M.D., Chief Commercial OfficerMs. Stephanie FaganChief Corporate Affairs Officer More Insider Trading Tools from MarketBeat Related Companies TLRY Insider Trades USNA Insider Trades CRON Insider Trades CDXC Insider Trades CGC Insider Trades BTMD Insider Trades FTLF Insider Trades MTEX Insider Trades BGXX Insider Trades UPXI Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking OnInsiders Are Buying High-Yielding Delek Logistics Partners This page (NASDAQ:MNMD) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mind Medicine (MindMed) Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mind Medicine (MindMed) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.